Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2025-12-25 @ 7:04 PM
NCT ID: NCT04860804
Description: None
Frequency Threshold: 0
Time Frame: 60 minutes
Study: NCT04860804
Study Brief: A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AOK Group Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin Aspirin and Ketamine: Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin 0 None 0 28 0 28 View
OK Group Drug: Proprietary oral formulation of 0.5mg/kg of ketamine Oral Ketamine: Proprietary oral formulation of 0.5mg/kg of ketamine 0 None 0 28 0 28 View
Serious Events(If Any):
Other Events(If Any):